Gefurulimab (anti-C5&Albumin)

抗体

C5药靶抗体 | ALB药靶抗体 | C5抗体 | ALB抗体 | Serum Albumin抗体 | 补体蛋白C5抗体 | 血清白蛋白抗体 | 白蛋白抗体

Anaphylatoxin C5a analog antibody | C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4 antibody | C5 antibody | C5a anaphylatoxin antibody | C5a antibody | C5b antibody | CO5_HUMAN antibody | Complement C5 alpha'' chain antibody | Complemen

Ab182984-100μg

100μg

无动物源

≥90%(SDS-PAGE&SEC-HPLC)

-80℃储存,避免反复冻融

超低温冰袋运输

短期储存2-8℃（1-2周）；长期储存-80℃（36个月）；收货后建议分装，避免反复冻融。

10mM PBS, pH 7.4.

C5: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled. Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. It induces the contraction of smooth muscle, increases vascular permeability and causes histamine release from mast cells and basophilic leukocytes. C5a also stimulates the locomotion of polymorphonuclear leukocytes (chemokinesis) and direct their migration toward sites of inflammation (chemotaxis). Serum Albumin: Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.

人(Human)

2456407-94-4

28.169 kDa

Unconjugated

重组抗体

Protein A purified

VH-VH'